{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-008455","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2025-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.169977+00:00","generated_at":"2026-05-22T16:11:27.303133+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Protagenic Therapeutics effects 1-for-14 reverse stock split to meet Nasdaq bid price rule","bullets":["Reverse stock split at 1-for-14 ratio effective 12:01 a.m. ET on May 5, 2025.","Approved by stockholders at April 18, 2025 special meeting; board set ratio to comply with Nasdaq Rule 5550(a)(2).","Common stock trades on Nasdaq under symbol PTIX with new CUSIP 74365N301; warrants continue under PTIXW.","Fractional shares rounded up; proportionate adjustments to outstanding options, warrants, and RSUs."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-008455","json":"https://secwatch.observer/filing/0001641172-25-008455.json","markdown":"https://secwatch.observer/filing/0001641172-25-008455.md","text":"https://secwatch.observer/filing/0001641172-25-008455.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000164117225008455/0001641172-25-008455-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000164117225008455/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T16:11:27.303133+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d38a875cd456d07de718d3c823cb73763ea1d63c","claim":"Protagenic Therapeutics, Inc.new: Approved and filed a certificate of amendment to effect a 1-for-14 reverse stock split of common stock (effective 2025-05-05).","evidence_excerpt":"On May 2, 2025, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment to its third amended and restated certificate of incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022899/000164117225008455/0001641172-25-008455-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}